Merck Ltd
Mumbai, Maharashtra
About Company
Description
At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Contact Information
Primary Email
Website
Registered Address
City
Mumbai
State
Maharashtra
Country
India
Business Information
Business Types
Manufacturer
Exporter
Manufacturing Units
1
Legal & Compliance
Certifications & Approvals
WHO-GMP
Certified
ISO
Not Certified
GMP
Not Certified
FSSAI
Not Certified
USFDA
Approved
EU-GMP
Not Certified
UK-MHRA
Not Approved
WHO Prequalified
No
PCD/Franchise Information
PCD Franchisor
No
Products
This company has 196 products. Showing first 100 products below.
| Product Name | Dosage Form | Composition | Therapeutic Category |
|---|---|---|---|
| ADE VALLEE® (multivitamin) Injection Multivitamin (with Soy Oil) Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed | Injection | - | Vitamins |
| ADE VALLEE® (multivitamin) Injection Multivitamin (with Soy Oil) Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed | Injection | - | Vitamins |
| ADEVIL® (multivitamin) Solution for Injection Multivitamin (with Sunflower Oil) Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are | Injection | - | Vitamins |
| ADEVIL® (multivitamin) Solution for Injection Multivitamin (with Sunflower Oil) Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are | Injection | - | Vitamins |
| ALBIPEN® (ampicillin) Suspension Ampicillin Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, promoted or dist | Suspension | - | - |
| ALBIPEN® (ampicillin) Suspension Ampicillin Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, promoted or dist | Suspension | - | - |
| AMPROVIL® 60% (amprolium) Powder for Oral Solution Amprolium Solid Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licens | Powder | - | - |
| AMPROVIL® 60% (amprolium) Powder for Oral Solution Amprolium Solid Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licens | Powder | - | - |
| Antistress Fish Multivitamin (with Starch) Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, promoted or distr | - | - | Vitamins |
| Antistress Fish Multivitamin (with Starch) Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, promoted or distr | - | - | Vitamins |
| Aqua C® Fish Plus Vitamin C (>10%) Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, promoted or distributed b | - | - | Vitamins |
| Aqua C® Fish Plus Vitamin C (>10%) Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, promoted or distributed b | - | - | Vitamins |
| Aqua C® Vitamin C Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, promoted or distributed by MSD, its subsid | - | - | Vitamins |
| Aqua C® Vitamin C Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, promoted or distributed by MSD, its subsid | - | - | Vitamins |
| AQUAFEN-L® (florfenicol) In-feed Antibiotic Florfenicol (2%) Liquid Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licen | - | - | Antibiotics |
| AQUAFEN-L® (florfenicol) In-feed Antibiotic Florfenicol (2%) Liquid Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licen | - | - | Antibiotics |
| AQUAFEN-L™ (florfenicol) In-feed Antibiotic Florfenicol (2%) Liquid Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licen | - | - | Antibiotics |
| AQUAFEN-L™ (florfenicol) In-feed Antibiotic Florfenicol (2%) Liquid Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licen | - | - | Antibiotics |
| AROVYN® (tulathromycin) Solution for Injection Tulathromycin Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, | Injection | - | - |
| AROVYN® (tulathromycin) Solution for Injection Tulathromycin Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, | Injection | - | - |
| ATROVIL® (atropine sulfate) Solution for Injection Atropine Sulfate Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licen | Injection | - | - |
| ATROVIL® (atropine sulfate) Solution for Injection Atropine Sulfate Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licen | Injection | - | - |
| AVELOX® (moxifloxacin hydrochloride) Tablets Moxifloxacin Solid Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed | Tablet | - | - |
| AVELOX® (moxifloxacin hydrochloride) Tablets Moxifloxacin Solid Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed | Tablet | - | - |
| AVELOX® I.V. (moxifloxacin hydrochloride) Injection, Solution for IV Use Moxifloxacin Liquid Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this | Injection | - | - |
| AVELOX® I.V. (moxifloxacin hydrochloride) Injection, Solution for IV Use Moxifloxacin Liquid Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this | Injection | - | - |
| AZIUM® (dexamethasone) Intramuscular Solution for Injection Dexamethasone (with Ethanol) Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this web | Injection | - | - |
| AZIUM® (dexamethasone) Intramuscular Solution for Injection Dexamethasone (with Ethanol) Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this web | Injection | - | - |
| AZIUM® (dexamethasone) Tablets Dexamethasone Solid Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, promoted | Tablet | - | - |
| AZIUM® (dexamethasone) Tablets Dexamethasone Solid Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, promoted | Tablet | - | - |
| B BCG Vaccine (For Percutaneous Use) Prescribing Information Instructions for Use BELSOMRA® (suvorexant) tablets, for oral use, C-IV Prescribing Information Medication Guide Product website BRIDION® ( | Tablet | - | - |
| B BCG Vaccine (For Percutaneous Use) Prescribing Information Instructions for Use BELSOMRA® (suvorexant) tablets, for oral use, C-IV Prescribing Information Medication Guide Product website BRIDION® ( | Tablet | - | - |
| BCG Vaccine (For Percutaneous Use) Prescribing Information Instructions for Use BELSOMRA® (suvorexant) tablets, for oral use, C-IV Prescribing Information Medication Guide Product website BRIDION® (su | Tablet | - | - |
| BCG Vaccine (For Percutaneous Use) Prescribing Information Instructions for Use BELSOMRA® (suvorexant) tablets, for oral use, C-IV Prescribing Information Medication Guide Product website BRIDION® (su | Tablet | - | - |
| BELSOMRA® (suvorexant) Tablet for Oral Use Suvorexant Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, promot | Tablet | - | - |
| BELSOMRA® (suvorexant) Tablet for Oral Use Suvorexant Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, promot | Tablet | - | - |
| BELSOMRA® (suvorexant) Tablets U.S. Patent No. 7,951,797 U.S. Patent No. 10,098,892 | Tablet | - | - |
| BELSOMRA® (suvorexant) Tablets U.S. Patent No. 7,951,797 U.S. Patent No. 10,098,892 | Tablet | - | - |
| BELSOMRA® (suvorexant) tablets, for oral use, C-IV Prescribing Information Medication Guide Product website | Tablet | - | - |
| BELSOMRA® (suvorexant) tablets, for oral use, C-IV Prescribing Information Medication Guide Product website | Tablet | - | - |
| BELSOMRA® (suvorexant) Tablets, for Oral Use, C-IV Suvorexant Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to | Tablet | - | - |
| BELSOMRA® (suvorexant) Tablets, for Oral Use, C-IV Suvorexant Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to | Tablet | - | - |
| BOOSTIN® (recombinant bovine somatotropin) Sustained-Release Injection Recombinant Bovine Somatotropin Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appeari | Injection | - | - |
| BOOSTIN® (recombinant bovine somatotropin) Sustained-Release Injection Recombinant Bovine Somatotropin Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appeari | Injection | - | - |
| BRAVECTO QUANTUM FLURALANER 150 mg/mL INJECTABLE SUSPENSION FOR DOGS Fluralaner Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, lice | Suspension | - | - |
| BRAVECTO QUANTUM FLURALANER 150 mg/mL INJECTABLE SUSPENSION FOR DOGS Fluralaner Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, lice | Suspension | - | - |
| BRIDION® (sugammadex sodium injection) For intravenous use U.S. Patent No. RE44,733 | Injection | - | - |
| BRIDION® (sugammadex sodium injection) For intravenous use U.S. Patent No. RE44,733 | Injection | - | - |
| BRIDION® (sugammadex) Injection, for intravenous use Prescribing Information | Injection | - | - |
| BRIDION® (sugammadex) Injection, for intravenous use Prescribing Information | Injection | - | - |
| BRIDION® (sugammadex) Solution for Injection Sugammadex Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, prom | Injection | - | - |
| BRIDION® (sugammadex) Solution for Injection Sugammadex Formulation Canada - English Canada - French_CA USA - English USA - Spanish_MX Trademarks appearing on this website are owned, licensed to, prom | Injection | - | - |
| C CANCIDAS® (caspofungin acetate) for Injection, for intravenous use Prescribing Information CAPVAXIVE™ (Pneumococcal 21 valent Conjugate Vaccine) Prescribing Information Patient Product Information | Injection | - | - |
| C CANCIDAS® (caspofungin acetate) for Injection, for intravenous use Prescribing Information CAPVAXIVE™ (Pneumococcal 21 valent Conjugate Vaccine) Prescribing Information Patient Product Information | Injection | - | - |
| CANCIDAS® (caspofungin acetate) for Injection, for intravenous use Prescribing Information | Injection | - | - |
| CANCIDAS® (caspofungin acetate) for Injection, for intravenous use Prescribing Information | Injection | - | - |
| CANCIDAS® (caspofungin acetate) for Injection, for intravenous use Prescribing Information CAPVAXIVE™ (Pneumococcal 21 valent Conjugate Vaccine) Prescribing Information Patient Product Information | Injection | - | - |
| CANCIDAS® (caspofungin acetate) for Injection, for intravenous use Prescribing Information CAPVAXIVE™ (Pneumococcal 21 valent Conjugate Vaccine) Prescribing Information Patient Product Information | Injection | - | - |
| CAPVAXIVE™ PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE Injection, for intramuscular use U.S. Patent No. 11,116,828 | Injection | - | - |
| CAPVAXIVE™ PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE Injection, for intramuscular use U.S. Patent No. 11,116,828 | Injection | - | - |
| D DELSTRIGO® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Prescribing Information Patient Product Information DIFICID® (fidaxomicin) for Oral Suspension DIFICID® ( | Tablet | - | - |
| D DELSTRIGO® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Prescribing Information Patient Product Information DIFICID® (fidaxomicin) for Oral Suspension DIFICID® ( | Tablet | - | - |
| DELSTRIGO® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Prescribing Information Patient Product Information | Tablet | - | - |
| DELSTRIGO® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Prescribing Information Patient Product Information | Tablet | - | - |
| DELSTRIGO® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Prescribing Information Patient Product Information DIFICID® (fidaxomicin) for Oral Suspension DIFICID® (fi | Tablet | - | - |
| DELSTRIGO® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Prescribing Information Patient Product Information DIFICID® (fidaxomicin) for Oral Suspension DIFICID® (fi | Tablet | - | - |
| DELSTRIGO® (doravirine/lamivudine/tenofovir disoproxil fumarate) Tablets U.S. Patent No. 8,486,975 U.S. Patent No. 10,603,282 U.S. Patent No. 10,842,751 | Tablet | - | - |
| DELSTRIGO® (doravirine/lamivudine/tenofovir disoproxil fumarate) Tablets U.S. Patent No. 8,486,975 U.S. Patent No. 10,603,282 U.S. Patent No. 10,842,751 | Tablet | - | - |
| DIFICID® (fidaxomicin) for Oral Suspension DIFICID® (fidaxomicin) tablets, for oral use Prescribing Information Patient Product Information | Tablet | - | - |
| DIFICID® (fidaxomicin) for Oral Suspension DIFICID® (fidaxomicin) tablets, for oral use Prescribing Information Patient Product Information | Tablet | - | - |
| DIFICID® (fidaxomicin) for Oral Suspension U.S. Patent No. 7,863,249 U.S. Patent No. 7,378,508 U.S. Patent No. 9,808,530 | Suspension | - | - |
| DIFICID® (fidaxomicin) for Oral Suspension U.S. Patent No. 7,863,249 U.S. Patent No. 7,378,508 U.S. Patent No. 9,808,530 | Suspension | - | - |
| DIFICID® (fidaxomicin) Tablets for oral use U.S. Patent No. 7,863,249 U.S. Patent No. 7,378,508 | Tablet | - | - |
| DIFICID® (fidaxomicin) Tablets for oral use U.S. Patent No. 7,863,249 U.S. Patent No. 7,378,508 | Tablet | - | - |
| E EMEND® (aprepitant) capsules (aprepitant) for oral suspension Prescribing Information Patient Product Information Instructions for Use EMEND® (fosaprepitant) for injection, for intravenous use Presc | Capsule | - | - |
| E EMEND® (aprepitant) capsules (aprepitant) for oral suspension Prescribing Information Patient Product Information Instructions for Use EMEND® (fosaprepitant) for injection, for intravenous use Presc | Capsule | - | - |
| efinopegdutide(MK-6024)Metabolic dysfunction-associated steatohepatitis(NCT04944992;NCT06465186;NCT05877547;NCT06482112)Therapeutic area:EndocrinologyMechanism of Action:Efinopegdutide is an investiga | Tablet | - | - |
| efinopegdutide(MK-6024)Metabolic dysfunction-associated steatohepatitis(NCT04944992;NCT06465186;NCT05877547;NCT06482112)Therapeutic area:EndocrinologyMechanism of Action:Efinopegdutide is an investiga | Tablet | - | - |
| EMEND® (aprepitant) capsules (aprepitant) for oral suspension Prescribing Information Patient Product Information Instructions for Use | Capsule | - | - |
| EMEND® (aprepitant) capsules (aprepitant) for oral suspension Prescribing Information Patient Product Information Instructions for Use | Capsule | - | - |
| EMEND® (aprepitant) capsules (aprepitant) for oral suspension Prescribing Information Patient Product Information Instructions for Use EMEND® (fosaprepitant) for injection, for intravenous use Prescri | Capsule | - | - |
| EMEND® (aprepitant) capsules (aprepitant) for oral suspension Prescribing Information Patient Product Information Instructions for Use EMEND® (fosaprepitant) for injection, for intravenous use Prescri | Capsule | - | - |
| EMEND® (aprepitant) Capsules 125/80 mg U.S. Patent No. 8,258,132 | Capsule | - | - |
| EMEND® (aprepitant) Capsules 125/80 mg U.S. Patent No. 8,258,132 | Capsule | - | - |
| EMEND® (aprepitant) Capsules 40mg U.S. Patent No. 8,258,132 | Capsule | - | - |
| EMEND® (aprepitant) Capsules 40mg U.S. Patent No. 8,258,132 | Capsule | - | - |
| EMEND® (aprepitant) for oral suspension (125 mg) U.S. Patent No. 8,258,132 | Suspension | - | - |
| EMEND® (aprepitant) for oral suspension (125 mg) U.S. Patent No. 8,258,132 | Suspension | - | - |
| EMEND® (fosaprepitant) for injection, for intravenous use Prescribing Information Patient Product Information | Injection | - | - |
| EMEND® (fosaprepitant) for injection, for intravenous use Prescribing Information Patient Product Information | Injection | - | - |
| ENFLONSIA™ (clesrovimab-cfor) injection, for intramuscular use Prescribing Information Patient Product Information | Injection | - | - |
| ENFLONSIA™ (clesrovimab-cfor) injection, for intramuscular use Prescribing Information Patient Product Information | Injection | - | - |
| ensifentrine (+) glycopyrrolate(MK-5884A)COPD(NCT07132983)Therapeutic area:RespiratoryMechanism of Action:Ensifentrine (+) glycopyrrolate is a combination of a selective dual inhibitor of phosphodiest | - | ensifentrine (+) glycopyrrolate(MK-5884A)Mechanism... | - |
| ensifentrine (+) glycopyrrolate(MK-5884A)COPD(NCT07132983)Therapeutic area:RespiratoryMechanism of Action:Ensifentrine (+) glycopyrrolate is a combination of a selective dual inhibitor of phosphodiest | - | ensifentrine (+) glycopyrrolate(MK-5884A)Mechanism... | - |
| ERVEBO® (Ebola Zaire Vaccine, Live) Suspension for intramuscular injection Prescribing Information Patient Product Information | Injection | - | - |
| ERVEBO® (Ebola Zaire Vaccine, Live) Suspension for intramuscular injection Prescribing Information Patient Product Information | Injection | - | - |
| G GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] Prescribing Information Patient Product Information GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Rec | Injection | - | - |
| G GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] Prescribing Information Patient Product Information GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Rec | Injection | - | - |
| GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] Prescribing Information Patient Product Information GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recom | Injection | - | - |
| GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] Prescribing Information Patient Product Information GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recom | Injection | - | - |
Social Media
Twitter
Company Status
Status
Active
Verification
Verified
Statistics
Profile Views
73
Total Inquiries
0